Extracted from text ... 56
BY THE WAY
There has been much debate recently on the issue of breast
cancer and hormone replacement therapy (HRT). The results
of the Million Women Study (MWS) reported a doubling of
the risk of breast cancer in current users of combined HRT
compared with never-users, along with increased mortality
among those women who developed breast cancer while
taking HRT. This has caused major scares among women,
their doctors and the pharmaceutical industry.
Correspondence in a recent issue of the Lancet is worth taking
a look at. A wide range of correspondents pointed out
what they saw as flaws ..